<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00570843</url>
  </required_header>
  <id_info>
    <org_study_id>0710009485</org_study_id>
    <nct_id>NCT00570843</nct_id>
  </id_info>
  <brief_title>Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision &amp; Wear Time in Patients Wearing Contact Lenses</brief_title>
  <official_title>Phase 4 Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision &amp; Wear Time in Patients Wearing Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bp Consulting, Inc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bp Consulting, Inc</source>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the effect of a new PEG based artificial tear as
      compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>vision and wear time</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Comfort, Vision and Wear Time</condition>
  <arm_group>
    <arm_group_label>1.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2.</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>New PEG based artificial tear</intervention_name>
    <description>1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)</description>
    <arm_group_label>1.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Optive</intervention_name>
    <description>1, 2, (in the eye) Instill one drop in the left eye or right eye four times daily (can be used more frequently if needed)</description>
    <arm_group_label>2.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Use of soft contact lenses (e.g. silicone hydrogel lenses, daily disposables etc.) and
             multipurpose solution for cleaning, including enzyme-based cleaners (ClearCare etc.)

          -  Able to wear contact lenses for approximately 10-12 hours/day

          -  Willingness to complete entire length of trial and comply with subjective
             questionnaire.

        Exclusion Criteria:

          -  Patients taking topical cyclosporine (Restasis)

          -  Patients currently using Optive for dryness relief.

          -  Patients wearing hard or rigid gas permeable lenses

          -  Patients with uncontrolled systemic disease which may confound the results of the
             trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Starr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New York Presbyterian Hospital Weill Cornell Medical College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The New York Presbyterian Hospital-Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2007</study_first_submitted>
  <study_first_submitted_qc>December 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2007</study_first_posted>
  <last_update_submitted>February 19, 2010</last_update_submitted>
  <last_update_submitted_qc>February 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Christopher Starr, MD</name_title>
    <organization>Weill Cornell Medical College- The New York Presbyterian Hospital</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

